Health care workers in low- and middle-income countries (LMICs) deal with many challenges in order to deliver the highest quality care. For example, many health care facilities (HCFs) lack adequate ...
Read more
Author: Leslie Jamka, Center for Vaccine Development at the University of Maryland School of Medicine
Trial kicks off in Malawi: First child vaccinated with typhoid conjugate vaccine in Africa
February 21, 2018, a day in vaccine history. The TyVAC Malawi team vaccinated the first African child with the newly pre-qualified typhoid conjugate vaccine, Typbar TCV®. Four-year-old Golden Kondowe is ...
Read more
Sequencing a superbug: How typhoid became extensively drug-resistant
The bacteria that causes typhoid fever, Salmonella Typhi, is a smart one. We know this because our laboratory has been sequencing the DNA of S. Typhi strains that infect people ...
Read more
Taking on typhoid in Bangladesh with icddr,b
On a recent visit to Dhaka, Bangladesh’s capital and largest city, I saw how much suffering occurs due to typhoid. From Dhaka Shishu Hospital – the country’s largest children’s hospital ...
Read more
Newly-prequalified typhoid conjugate vaccine used in outbreak response
Health officials and local researchers have launched an emergency vaccination campaign to stem an outbreak of ceftriaxone-resistant typhoid in Hyderabad, Pakistan. The outbreak has sickened more than 800 people since ...
Read moreTake On Typhoid Newsletter January 2018
See past issues in our Newsletter Archives In this issue: Typhoid conjugate vaccine is first to receive WHO prequalification Looking back on a year of progress Aga Khan University launches ...
Read more
Stories of Typhoid: The Lama Family
On April 25, 2015, this family of four had their lives turned upside-down by the deadly earthquake that devastated Nepal. One year later, almost to the day, their lives were ...
Read moreFirst typhoid conjugate vaccine achieves WHO prequalification, a key step in protecting children and reducing the burden of typhoid
Geneva, Switzerland – January 3, 2018 – A typhoid conjugate vaccine has been prequalified by the World Health Organization (WHO), bringing the vaccine one step closer to reaching millions more ...
Read more
Typbar TCV® Prequalification: Questions and Answers
The first typhoid conjugate vaccine has been prequalified by the World Health Organization. Learn what this means for typhoid prevention and control around the world, and how this can help us take ...
Read more
Celebrating prequalification—a major milestone in typhoid prevention efforts
This week, our team is celebrating a big milestone: the news that the World Health Organization (WHO) prequalified Typbar TCV®, a vaccine manufactured by Bharat Biotech. This is the first ...
Read more
